Learn how Poly Alpha Olefin (PAO) is used for HEPA filter integrity testing during pharmaceutical HVAC validation, including its properties and test principles.

Poly Alpha Olefin (PAO) Used in HVAC Validation and HEPA Filter Integrity Testing

Poly Alpha Olefin (PAO) is a commonly used aerosol challenge material for HEPA filter leak or integrity testing in pharmaceutical HVAC and cleanroom systems. During an in-situ test, a PAO aerosol is introduced upstream of the HEPA filter, and the downstream side of the filter, frame, and sealing area is scanned with an aerosol photometer to detect leakage.

The important distinction is that an installed HEPA filter leak test is not the same as a filter-efficiency test performed by the filter manufacturer. The in-situ test is intended to identify leaks through the filter media, frame, gasket, or installation. FDA guidance identifies both DOP and PAO as examples of suitable aerosols for HEPA filter leak testing and states that alternative aerosols may be used when their relevant properties are appropriate.

What Is Poly Alpha Olefin (PAO)?

Poly Alpha Olefin (PAO) is a synthetic hydrocarbon fluid produced from alpha-olefin feedstocks. PAO products used for aerosol generation are formulated to provide suitable physical characteristics for generating a stable challenge aerosol during high-efficiency filter leak testing.

The term poly-alpha-olefin describes a family of synthetic hydrocarbons rather than one single molecular structure. Commercial PAO materials can therefore differ in composition depending on the grade and manufacturer.

PAOs are also widely used outside cleanroom testing, particularly as synthetic lubricants and in applications where controlled viscosity and thermal stability are useful.

PAO and Its Molecular Structure

An alpha-olefin is an alkene in which the carbon-carbon double bond occurs at the terminal position of the carbon chain. Polymerization or oligomerization of suitable alpha-olefin molecules produces higher-molecular-weight hydrocarbon materials.

For this reason, it is more accurate to describe PAO as a family of synthetic hydrocarbon oligomers/polymers rather than assigning one simple molecular structure to every PAO product.

Some PAO aerosol products are based on oligomeric materials derived from linear alpha-olefins such as decene. The exact composition should be confirmed from the manufacturer's specification or Safety Data Sheet (SDS) for the particular product used in a validation program.

Why Is PAO Used for HEPA Filter Integrity Testing?

PAO is used because it can be aerosolized into a suitable submicron challenge and detected downstream with an aerosol photometer.

The basic principle is straightforward:

1. Generate the PAO aerosol.

2. Introduce the aerosol upstream of the HEPA filter.

3. Establish an appropriate and sufficiently uniform upstream challenge.

4. Scan the downstream face of the filter.

5. Scan or evaluate the filter frame and sealing areas as applicable.

6. Compare downstream readings with the upstream challenge.

7. Investigate any result that exceeds the established acceptance criterion.

FDA guidance describes the use of a polydispersed submicron aerosol for in-situ HEPA leak testing and emphasizes that an adequate upstream challenge is necessary for effective leak detection.

PAO in Pharmaceutical HVAC Validation

In pharmaceutical facilities, HEPA filters are an important component of HVAC systems serving controlled and aseptic environments. During qualification and periodic verification, the integrity of installed filters may need to be demonstrated according to the site's approved validation program and applicable standards.

The PAO aerosol test can help identify defects such as:

• Damage to HEPA filter media

• Leakage around the filter frame

• Gasket or seal leakage

• Installation-related leakage

• Localized penetration through the filter

• Other defects that allow the challenge aerosol to bypass the intended filtration barrier

IEST-RP-CC034.5 specifically covers HEPA and ULPA filter leak testing in factories, at job sites, and after installation in cleanrooms and unidirectional-flow clean-air devices. It also addresses the uniformity of the aerosol challenge approaching the filter.

PAO HEPA Filter Integrity Test: How Does It Work?

A typical in-situ PAO leak test follows the principle below.

Step 1: Prepare the Test Equipment

The test setup generally includes:

• PAO aerosol generator

• PAO aerosol

• Aerosol photometer or another suitable detection instrument

• Sampling probe

• Appropriate tubing and sampling arrangement

• Upstream aerosol concentration measurement capability, where required

• Calibrated test instruments

The equipment should be maintained and calibrated according to the manufacturer's requirements and the site's approved procedure.

Step 2: Generate the PAO Aerosol

The aerosol generator produces a controlled aerosol challenge upstream of the HEPA filter.

The objective is not simply to create "as much aerosol as possible." The challenge should be suitable for the measurement system and sufficiently uniform across the filter under test.

FDA guidance specifically notes that the aerosol concentration upstream should be appropriate for the accuracy of the aerosol photometer.

Step 3: Establish the Upstream Challenge

Before scanning the filter, the test operator establishes the upstream challenge concentration.

This step is important because the downstream measurement is interpreted relative to the upstream challenge. An inadequate or non-uniform challenge can compromise the ability of the test to detect leakage.

Step 4: Scan the Downstream Filter Surface

The downstream face of the HEPA filter is systematically scanned with the photometer probe.

The operator should follow the applicable test procedure for:

• Probe position

• Scanning speed

• Sampling rate

• Distance from the filter face

• Filter coverage

• Frame and gasket examination

FDA guidance describes scanning the entire filter face and frame and recommends a probe sampling rate of at least 1 cubic foot per minute for the described method.

Step 5: Investigate Any Indication of Leakage

If a significant downstream indication is observed, the location should be identified and investigated according to the approved procedure.

Potential causes include:

• Damaged filter media

• Poor gasket compression

• Damaged gasket

• Frame leakage

• Improper installation

• Seal failure

• Physical damage to the filter

IEST-RP-CC034.5 includes procedures for leak detection and characterization of detected leakage.

PAO Leak Test vs HEPA Filter Efficiency Test

One of the most important points when discussing PAO testing is to distinguish filter efficiency from installed filter leak testing.

Feature	HEPA Filter Efficiency Test	Installed HEPA Leak Test
Main purpose	Determine filtration efficiency	Detect leakage in the installed filter system
Typical location	Filter manufacturing/test facility	Cleanroom or installed HVAC system
Main concern	Filter media performance	Media, frame, gasket, seal and installation
Aerosol challenge	Defined test aerosol	Suitable aerosol challenge, such as PAO
Detection	May use particle-counting methods	Commonly aerosol photometry or another specified method
Result	Filter efficiency/penetration	Localized or total leakage assessment
Typical application	Filter qualification/manufacturing	HVAC/cleanroom qualification and periodic testing

ISO 14644-3 distinguishes the installed filter-system leak test from the efficiency test of an individual filter at the place of manufacture. The installed test evaluates the complete filter installation, including components such as the filter media, frame, gasket and grid system.

Is 99.97% the Acceptance Criterion for a PAO Leak Test?

Not necessarily.

The statement that a HEPA filter should provide 99.97% efficiency at 0.3 µm should not automatically be interpreted as the acceptance criterion for every in-situ PAO leak test.

A 99.97% efficiency rating corresponds to approximately 0.03% penetration under the applicable efficiency-test conditions. FDA materials describe this rating in the context of HEPA filter efficiency testing.

An installed filter leak test has a different purpose. Its acceptance criterion depends on the applicable test method, filter/system specification, facility procedure, and validation requirements.

For example, FDA's aseptic-processing guidance describes a downstream probe reading equivalent to 0.01% of the upstream challenge as indicative of a significant leak for the particular leak-testing approach described in that guidance.

Therefore, a pharmaceutical validation protocol should not simply copy the 99.97% HEPA efficiency value as the in-situ PAO leak-test limit.

What Particle Size Does PAO Produce?

PAO aerosol generators can produce a submicron aerosol suitable for HEPA filter leak testing. The actual aerosol particle-size distribution depends on factors such as:

• Aerosol generator design

• PAO formulation

• Generator operating conditions

• Temperature

• Pressure

• Airflow

• Test configuration

Therefore, a statement such as "PAO always produces particles from 0.1 to 1.0 µm" should not be treated as a universal specification.

The appropriate aerosol characteristics should be established using the specific aerosol generator, aerosol material and test method used at the facility.

FDA guidance describes the challenge aerosol for HEPA leak testing as generally polydispersed with a light-scattering mean droplet diameter in the submicron range and with a sufficient number of particles around the relevant test region.

Why Was PAO Adopted as an Alternative to DOP?

Historically, dioctyl phthalate (DOP) was widely used in aerosol-based HEPA filter testing. PAO became an important alternative because it provides suitable aerosol characteristics for high-efficiency filter testing without relying on the traditional DOP aerosol.

However, the common statement that "DOP is a carcinogen" is too broad and should not be presented without specifying the particular phthalate, exposure route and toxicological evidence.

The regulatory and toxicological status of individual phthalates differs. Consequently, pharmaceutical facilities should evaluate the actual material being used and follow current safety documentation rather than relying on generalized statements about all phthalates.

FDA guidance specifically identifies both DOP and PAO as examples of appropriate HEPA filter leak-testing aerosols and states that alternative aerosols can be acceptable when their critical physicochemical characteristics are suitable.

What Are the Advantages of PAO in HVAC Validation?

PAO offers several practical advantages for pharmaceutical cleanroom and HVAC filter testing.

1. Suitable for Aerosol Challenge Testing

PAO can be aerosolized to produce a challenge suitable for detecting leakage through high-efficiency filtration systems.

2. Compatible With Photometric Detection

The aerosol can be measured using an aerosol photometer, allowing the operator to compare downstream measurements with the established upstream challenge.

3. Useful for In-Situ Testing

PAO testing can be performed on installed HEPA filters, making it useful during cleanroom commissioning, qualification and periodic verification.

4. Helps Detect Installation Problems

The test is not limited to filter media. Depending on the test configuration, it can help identify leakage at the filter frame, gasket and other parts of the installed filter assembly.

5. Established Industry Practice

HEPA/ULPA filter leak-testing practices are covered by recognized technical documents such as IEST-RP-CC034.5.

What Are the Limitations of PAO Testing?

PAO testing is valuable, but it should not be considered a complete assessment of HVAC performance.

A successful filter leak test does not by itself demonstrate that an entire cleanroom HVAC system is qualified.

Other aspects of cleanroom and HVAC performance may include:

• Airflow measurement

• Airflow velocity

• Airflow visualization

• Pressure differential

• Recovery performance

• Temperature and relative humidity

• Non-viable particle classification

• Microbiological environmental monitoring

• HEPA filter installation integrity

• Alarm and monitoring-system performance

FDA guidance also emphasizes that HEPA leak testing alone is insufficient to monitor overall filter/system performance and discusses the importance of airflow characteristics and other controls.

PAO Storage and Shelf Life

PAO storage requirements are product-specific. It is therefore better not to state a universal shelf life such as "10 years sealed and one year after opening" unless that period is explicitly supported by the manufacturer's current product documentation.

For a pharmaceutical facility, the PAO used for validation should be controlled according to the supplier's:

• Certificate of Analysis (CoA)

• Safety Data Sheet (SDS)

• Product specification

• Recommended storage conditions

• Lot/batch information

• Expiry or retest date, where applicable

The material should generally be protected from contamination and stored under the conditions specified by the manufacturer. If the supplier specifies protection from excessive heat, light or direct sunlight, those conditions should be followed.

Practical Considerations Before Performing a PAO HEPA Leak Test

Before starting a qualification or requalification test, verify the following:

Check	Why It Matters
Aerosol identity	Confirms that the correct test material is being used
PAO lot/batch	Provides traceability
Product expiry/retest status	Confirms suitability of the material
Generator condition	Supports consistent aerosol generation
Photometer calibration	Ensures reliable measurement
Upstream challenge	Provides the reference concentration
Challenge uniformity	Helps ensure representative testing
Filter identification	Maintains traceability of individual HEPA filters
Approved test procedure	Defines the test method and acceptance criteria
Environmental/HVAC state	Ensures the system is tested under the intended qualification condition
Test records	Provides objective evidence for qualification/requalification

Common Mistakes During PAO HEPA Filter Testing

Mistake 1: Confusing Efficiency With Leak Testing

A 99.97% HEPA efficiency rating is not automatically the acceptance limit for an installed PAO leak test.

Mistake 2: Using an Inadequate Aerosol Challenge

If the upstream challenge is insufficient or poorly distributed, the test may not reliably identify leakage.

Mistake 3: Ignoring the Filter Frame and Gasket

Leakage can occur around the filter assembly rather than through the filter media itself.

Mistake 4: Using an Uncalibrated Photometer

Instrument calibration and verification are essential to obtaining defensible measurements.

Mistake 5: Treating PAO as a Single Chemical

Commercial PAO materials are not necessarily identical. The exact composition and properties depend on the product and manufacturer.

Mistake 6: Applying a Generic Shelf-Life Claim

Storage life should be based on the manufacturer's documentation for the specific PAO product.

Mistake 7: Treating PAO Testing as Complete HVAC Qualification

A HEPA integrity test is one component of a broader HVAC and cleanroom qualification program.

What Standards and Guidance Are Relevant?

The exact requirements applicable to a pharmaceutical facility depend on the facility, process, jurisdiction and validation strategy. Useful authoritative or technical references include:

• FDA Guidance for Industry – Sterile Drug Products Produced by Aseptic Processing: discusses HEPA filter integrity and leak testing and identifies DOP and PAO as examples of suitable challenge aerosols.

• ISO 14644-3: provides cleanroom test methods and distinguishes installed filter-system leakage testing from filter efficiency testing.

• IEST-RP-CC034.5: covers HEPA and ULPA filter leak testing, including in-situ testing and aerosol challenge considerations.

• IEST-RP-CC007.4: addresses efficiency testing of HEPA, ULPA and super-ULPA filters and particle penetration measurements.

These documents should be used according to their applicable scope. A facility's approved SOP, validation protocol and applicable regulatory requirements should determine the actual test procedure and acceptance criteria.

PAO HEPA Filter Integrity Testing: Key Takeaways

• Poly Alpha Olefin (PAO) is a synthetic hydrocarbon material commonly used as an aerosol challenge for HEPA filter leak testing.

• PAO is used during in-situ HEPA filter integrity/leak testing in cleanrooms and HVAC systems.

• A PAO aerosol is generated upstream of the filter and measured downstream using an aerosol photometer or another specified detection method.

• The installed leak test evaluates more than filter media; it can also identify leakage associated with the frame, gasket, seal and installation.

• 99.97% efficiency at 0.3 µm should not automatically be used as the acceptance criterion for an installed PAO leak test.

• FDA identifies PAO and DOP as examples of appropriate aerosols for HEPA leak testing and permits consideration of alternative aerosols when their critical properties are appropriate.

• PAO storage conditions and shelf life should be taken from the specific manufacturer's product documentation, not from a universal industry claim.

• PAO filter testing is only one part of a broader pharmaceutical HVAC and cleanroom qualification program.

Frequently Asked Questions About PAO in HVAC Validation

What is PAO used for in pharmaceutical HVAC systems?

PAO is primarily used as an aerosol challenge material for HEPA filter leak or integrity testing. It allows the test operator to introduce a detectable aerosol upstream of an installed HEPA filter and evaluate the downstream filter surface and installation for leakage.

Why is PAO used instead of DOP?

PAO provides a suitable aerosol challenge for HEPA filter leak testing and is recognized by FDA guidance as an example of an appropriate aerosol. The choice of aerosol should be based on the test method, required physicochemical properties, safety considerations and facility procedure.

Is PAO a polymer?

PAO refers to a family of synthetic hydrocarbons produced from alpha-olefin feedstocks. Commercial PAO products can contain different oligomeric compositions, so the exact molecular composition should be obtained from the manufacturer's technical documentation.

What is the purpose of the PAO aerosol in a HEPA filter test?

The PAO aerosol acts as a challenge aerosol. If the installed HEPA filter and its sealing system are intact, the downstream concentration should remain within the established acceptance criteria. A localized increase can indicate leakage that requires investigation.

Is 99.97% the PAO leak-test acceptance limit?

No. 99.97% is commonly associated with the rated efficiency of a HEPA filter under specified test conditions. It should not automatically be treated as the acceptance criterion for an in-situ PAO leak test. The applicable test standard, protocol and facility procedure should define the acceptance criterion.

What instrument is used for PAO HEPA filter testing?

An aerosol photometer is commonly used for PAO-based HEPA filter leak testing. The instrument detects the aerosol concentration and allows downstream measurements to be evaluated against the upstream challenge.

Does PAO testing qualify the entire HVAC system?

No. PAO HEPA filter testing verifies an important aspect of filtration-system integrity, but it does not by itself qualify the entire HVAC or cleanroom system. Other qualification activities may include airflow, pressure differential, airflow visualization, temperature, humidity and particle-related tests.

How long can PAO be stored?

There is no universal shelf-life value that should be applied to every PAO product. Storage life and conditions should be taken from the manufacturer's current specification, CoA, SDS or label for the particular product.